148 related articles for article (PubMed ID: 2022560)
1. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength.
Cuneo RC; Salomon F; Wiles CM; Hesp R; Sönksen PH
J Appl Physiol (1985); 1991 Feb; 70(2):688-94. PubMed ID: 2022560
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance.
Cuneo RC; Salomon F; Wiles CM; Hesp R; Sönksen PH
J Appl Physiol (1985); 1991 Feb; 70(2):695-700. PubMed ID: 2022561
[TBL] [Abstract][Full Text] [Related]
3. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.
Janssen YJ; Doornbos J; Roelfsema F
J Clin Endocrinol Metab; 1999 Jan; 84(1):279-84. PubMed ID: 9920096
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.
Whitehead HM; Boreham C; McIlrath EM; Sheridan B; Kennedy L; Atkinson AB; Hadden DR
Clin Endocrinol (Oxf); 1992 Jan; 36(1):45-52. PubMed ID: 1559299
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
7. Long-term growth hormone treatment in growth hormone deficient adults.
Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Møller J; Müller J; Skakkebaek NE; Christiansen JS
Acta Endocrinol (Copenh); 1991 Nov; 125(5):449-53. PubMed ID: 1759534
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients.
Chu LW; Lam KS; Tam SC; Hu WJ; Hui SL; Chiu A; Chiu KC; Ng P
J Clin Endocrinol Metab; 2001 May; 86(5):1913-20. PubMed ID: 11344184
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people.
Hennessey JV; Chromiak JA; DellaVentura S; Reinert SE; Puhl J; Kiel DP; Rosen CJ; Vandenburgh H; MacLean DB
J Am Geriatr Soc; 2001 Jul; 49(7):852-8. PubMed ID: 11527474
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson BA; Edén S; Lönn L; Kvist H; Stokland A; Lindstedt G; Bosaeus I; Tölli J; Sjöström L; Isaksson OG
J Clin Endocrinol Metab; 1993 Feb; 76(2):309-17. PubMed ID: 8432773
[TBL] [Abstract][Full Text] [Related]
11. What are the clinical benefits of correcting the catabolic state in haemodialysis patients?
Jensen PB; Hansen TB; Oxhøj H; Froberg K; Ekelund B; Nielsen FT; Pedersen FB
Br J Clin Pract Suppl; 1996 Aug; 85():47-51. PubMed ID: 8995031
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of growth hormone treatment in GH-deficient adults.
Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement.
Weissberger AJ; Anastasiadis AD; Sturgess I; Martin FC; Smith MA; Sönksen PH
Clin Endocrinol (Oxf); 2003 Jan; 58(1):99-107. PubMed ID: 12519419
[TBL] [Abstract][Full Text] [Related]
14. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
15. Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults.
Rutherford OM; Jones DA; Round JM; Buchanan CR; Preece MA
Clin Endocrinol (Oxf); 1991 Jun; 34(6):469-75. PubMed ID: 1889131
[TBL] [Abstract][Full Text] [Related]
16. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study.
Burdet L; de Muralt B; Schutz Y; Pichard C; Fitting JW
Am J Respir Crit Care Med; 1997 Dec; 156(6):1800-6. PubMed ID: 9412558
[TBL] [Abstract][Full Text] [Related]
17. Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.
Woodhouse LJ; Asa SL; Thomas SG; Ezzat S
J Clin Endocrinol Metab; 1999 Dec; 84(12):4570-7. PubMed ID: 10599721
[TBL] [Abstract][Full Text] [Related]
18. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
Salomon F; Cuneo RC; Hesp R; Sönksen PH
N Engl J Med; 1989 Dec; 321(26):1797-803. PubMed ID: 2687691
[TBL] [Abstract][Full Text] [Related]
19. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
[TBL] [Abstract][Full Text] [Related]
20. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
